<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Thu, 30 Jul 2026 16:15:49 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>DeepHealth wins FDA clearance for AI breast ultrasound tool</title>
   <link>http://www.streetinsider.com/Corporate+News/DeepHealth+wins+FDA+clearance+for+AI+breast+ultrasound+tool/26843839.html</link>
   <description>&lt;p&gt;DeepHealth, Inc., a subsidiary of RadNet, Inc. (NASDAQ: RDNT), has received FDA 510(k) clearance for DeepHealth Breast Ultrasound, an AI-powered tool designed to automate lesion detection, characterization, and reporting in breast ultrasound imaging.&lt;/p&gt;&lt;p&gt;The clearance, issued under 510(k) K260303, covers a device manufactured by See-Mode Technologies Pty Ltd, a DeepHealth company, and distributed in the United States by DeepHealth, Inc. The product is now commercially available for sale in the U.S., with customers able to pursue reimbursement under an existing Category III CPT code for quantitative ultrasound tissue characterization, subject to payer policy.&lt;/p&gt;&lt;p&gt;According to a multi-reader multi-case study involving 16 U.S.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/DeepHealth+wins+FDA+clearance+for+AI+breast+ultrasound+tool/26843839.html</guid>
   <pubDate>Thu, 30 Jul 2026 16:15:49 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">RDNT</category>
   	  </item>
  <item>
   <title>DeepHealth wins FDA clearance for AI breast ultrasound tool</title>
   <link>http://www.streetinsider.com/FDA/DeepHealth+wins+FDA+clearance+for+AI+breast+ultrasound+tool/26843839.html</link>
   <description>&lt;p&gt;DeepHealth, Inc., a subsidiary of RadNet, Inc. (NASDAQ: RDNT), has received FDA 510(k) clearance for DeepHealth Breast Ultrasound, an AI-powered tool designed to automate lesion detection, characterization, and reporting in breast ultrasound imaging.&lt;/p&gt;&lt;p&gt;The clearance, issued under 510(k) K260303, covers a device manufactured by See-Mode Technologies Pty Ltd, a DeepHealth company, and distributed in the United States by DeepHealth, Inc. The product is now commercially available for sale in the U.S., with customers able to pursue reimbursement under an existing Category III CPT code for quantitative ultrasound tissue characterization, subject to payer policy.&lt;/p&gt;&lt;p&gt;According to a multi-reader multi-case study involving 16 U.S.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/FDA/DeepHealth+wins+FDA+clearance+for+AI+breast+ultrasound+tool/26843839.html</guid>
   <pubDate>Thu, 30 Jul 2026 16:15:49 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">RDNT</category>
   	  </item>
  <item>
   <title>DeepHealth Receives FDA Clearance for AI-Powered Breast Ultrasound</title>
   <link>http://www.streetinsider.com/Press+Releases/DeepHealth+Receives+FDA+Clearance+for+AI-Powered+Breast+Ultrasound/26843821.html</link>
   <description>
&lt;p&gt;SOMERVILLE, Mass., July  30, 2026  (GLOBE NEWSWIRE) -- DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (NASDAQ: RDNT), today announced FDA 510(k) clearance for DeepHealth Breast Ultrasound,1 an AI-powered solution that brings greater standardization, clinical accuracy and efficiency to breast ultrasound imaging. DeepHealth Breast Ultrasound automates lesion detection, characterization and reporting, streamlining sonographer and radiologist workflows in one intelligent experience. Together with its AI-powered mammography solutions, the expanded DeepHealth breast platform is the most comprehensive in the industry.&lt;/p&gt;  &lt;p&gt;In addition to a multi-reader multi-case study involving 16 U.S.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/DeepHealth+Receives+FDA+Clearance+for+AI-Powered+Breast+Ultrasound/26843821.html</guid>
   <pubDate>Thu, 30 Jul 2026 16:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216686</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00175066</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.40307675</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RDNT</category>
   	  </item>
  <item>
   <title>DeepHealth Receives FDA Clearance for AI-Powered Breast Ultrasound</title>
   <link>http://www.streetinsider.com/Press+Releases/DeepHealth+Receives+FDA+Clearance+for+AI-Powered+Breast+Ultrasound/26843821.html</link>
   <description>
&lt;p&gt;SOMERVILLE, Mass., July  30, 2026  (GLOBE NEWSWIRE) -- DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (NASDAQ: RDNT), today announced FDA 510(k) clearance for DeepHealth Breast Ultrasound,1 an AI-powered solution that brings greater standardization, clinical accuracy and efficiency to breast ultrasound imaging. DeepHealth Breast Ultrasound automates lesion detection, characterization and reporting, streamlining sonographer and radiologist workflows in one intelligent experience. Together with its AI-powered mammography solutions, the expanded DeepHealth breast platform is the most comprehensive in the industry.&lt;/p&gt;  &lt;p&gt;In addition to a multi-reader multi-case study involving 16 U.S.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/DeepHealth+Receives+FDA+Clearance+for+AI-Powered+Breast+Ultrasound/26843821.html</guid>
   <pubDate>Thu, 30 Jul 2026 16:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216686</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00175066</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.40307675</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RDNT</category>
   	  </item>
  <item>
   <title>DeepHealth Receives FDA Clearance for AI-Powered Breast Ultrasound</title>
   <link>http://www.streetinsider.com/Press+Releases/DeepHealth+Receives+FDA+Clearance+for+AI-Powered+Breast+Ultrasound/26843821.html</link>
   <description>
&lt;p&gt;SOMERVILLE, Mass., July  30, 2026  (GLOBE NEWSWIRE) -- DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (NASDAQ: RDNT), today announced FDA 510(k) clearance for DeepHealth Breast Ultrasound,1 an AI-powered solution that brings greater standardization, clinical accuracy and efficiency to breast ultrasound imaging. DeepHealth Breast Ultrasound automates lesion detection, characterization and reporting, streamlining sonographer and radiologist workflows in one intelligent experience. Together with its AI-powered mammography solutions, the expanded DeepHealth breast platform is the most comprehensive in the industry.&lt;/p&gt;  &lt;p&gt;In addition to a multi-reader multi-case study involving 16 U.S.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/DeepHealth+Receives+FDA+Clearance+for+AI-Powered+Breast+Ultrasound/26843821.html</guid>
   <pubDate>Thu, 30 Jul 2026 16:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216686</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00175066</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.40307675</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RDNT</category>
   	  </item>
  <item>
   <title>DeepHealth Receives FDA Clearance for AI-Powered Breast Ultrasound</title>
   <link>http://www.streetinsider.com/Press+Releases/DeepHealth+Receives+FDA+Clearance+for+AI-Powered+Breast+Ultrasound/26843821.html</link>
   <description>
&lt;p&gt;SOMERVILLE, Mass., July  30, 2026  (GLOBE NEWSWIRE) -- DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (NASDAQ: RDNT), today announced FDA 510(k) clearance for DeepHealth Breast Ultrasound,1 an AI-powered solution that brings greater standardization, clinical accuracy and efficiency to breast ultrasound imaging. DeepHealth Breast Ultrasound automates lesion detection, characterization and reporting, streamlining sonographer and radiologist workflows in one intelligent experience. Together with its AI-powered mammography solutions, the expanded DeepHealth breast platform is the most comprehensive in the industry.&lt;/p&gt;  &lt;p&gt;In addition to a multi-reader multi-case study involving 16 U.S.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/DeepHealth+Receives+FDA+Clearance+for+AI-Powered+Breast+Ultrasound/26843821.html</guid>
   <pubDate>Thu, 30 Jul 2026 16:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216686</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00175066</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.40307675</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RDNT</category>
   	  </item>
  <item>
   <title>DeepHealth Receives FDA Clearance for AI-Powered Breast Ultrasound</title>
   <link>http://www.streetinsider.com/Globe+Newswire/DeepHealth+Receives+FDA+Clearance+for+AI-Powered+Breast+Ultrasound/26843821.html</link>
   <description>
&lt;p&gt;SOMERVILLE, Mass., July  30, 2026  (GLOBE NEWSWIRE) -- DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (NASDAQ: RDNT), today announced FDA 510(k) clearance for DeepHealth Breast Ultrasound,1 an AI-powered solution that brings greater standardization, clinical accuracy and efficiency to breast ultrasound imaging. DeepHealth Breast Ultrasound automates lesion detection, characterization and reporting, streamlining sonographer and radiologist workflows in one intelligent experience. Together with its AI-powered mammography solutions, the expanded DeepHealth breast platform is the most comprehensive in the industry.&lt;/p&gt;  &lt;p&gt;In addition to a multi-reader multi-case study involving 16 U.S.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/DeepHealth+Receives+FDA+Clearance+for+AI-Powered+Breast+Ultrasound/26843821.html</guid>
   <pubDate>Thu, 30 Jul 2026 16:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216686</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00175066</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.40307675</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RDNT</category>
   	  </item>
  <item>
   <title>DeepHealth Receives FDA Clearance for AI-Powered Breast Ultrasound</title>
   <link>http://www.streetinsider.com/Globe+Newswire/DeepHealth+Receives+FDA+Clearance+for+AI-Powered+Breast+Ultrasound/26843821.html</link>
   <description>
&lt;p&gt;SOMERVILLE, Mass., July  30, 2026  (GLOBE NEWSWIRE) -- DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (NASDAQ: RDNT), today announced FDA 510(k) clearance for DeepHealth Breast Ultrasound,1 an AI-powered solution that brings greater standardization, clinical accuracy and efficiency to breast ultrasound imaging. DeepHealth Breast Ultrasound automates lesion detection, characterization and reporting, streamlining sonographer and radiologist workflows in one intelligent experience. Together with its AI-powered mammography solutions, the expanded DeepHealth breast platform is the most comprehensive in the industry.&lt;/p&gt;  &lt;p&gt;In addition to a multi-reader multi-case study involving 16 U.S.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/DeepHealth+Receives+FDA+Clearance+for+AI-Powered+Breast+Ultrasound/26843821.html</guid>
   <pubDate>Thu, 30 Jul 2026 16:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216686</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00175066</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.40307675</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RDNT</category>
   	  </item>
  <item>
   <title>DeepHealth Receives FDA Clearance for AI-Powered Breast Ultrasound</title>
   <link>http://www.streetinsider.com/Globe+Newswire/DeepHealth+Receives+FDA+Clearance+for+AI-Powered+Breast+Ultrasound/26843821.html</link>
   <description>
&lt;p&gt;SOMERVILLE, Mass., July  30, 2026  (GLOBE NEWSWIRE) -- DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (NASDAQ: RDNT), today announced FDA 510(k) clearance for DeepHealth Breast Ultrasound,1 an AI-powered solution that brings greater standardization, clinical accuracy and efficiency to breast ultrasound imaging. DeepHealth Breast Ultrasound automates lesion detection, characterization and reporting, streamlining sonographer and radiologist workflows in one intelligent experience. Together with its AI-powered mammography solutions, the expanded DeepHealth breast platform is the most comprehensive in the industry.&lt;/p&gt;  &lt;p&gt;In addition to a multi-reader multi-case study involving 16 U.S.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/DeepHealth+Receives+FDA+Clearance+for+AI-Powered+Breast+Ultrasound/26843821.html</guid>
   <pubDate>Thu, 30 Jul 2026 16:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216686</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00175066</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.40307675</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RDNT</category>
   	  </item>
  <item>
   <title>DeepHealth Receives FDA Clearance for AI-Powered Breast Ultrasound</title>
   <link>http://www.streetinsider.com/Globe+Newswire/DeepHealth+Receives+FDA+Clearance+for+AI-Powered+Breast+Ultrasound/26843821.html</link>
   <description>
&lt;p&gt;SOMERVILLE, Mass., July  30, 2026  (GLOBE NEWSWIRE) -- DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (NASDAQ: RDNT), today announced FDA 510(k) clearance for DeepHealth Breast Ultrasound,1 an AI-powered solution that brings greater standardization, clinical accuracy and efficiency to breast ultrasound imaging. DeepHealth Breast Ultrasound automates lesion detection, characterization and reporting, streamlining sonographer and radiologist workflows in one intelligent experience. Together with its AI-powered mammography solutions, the expanded DeepHealth breast platform is the most comprehensive in the industry.&lt;/p&gt;  &lt;p&gt;In addition to a multi-reader multi-case study involving 16 U.S.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/DeepHealth+Receives+FDA+Clearance+for+AI-Powered+Breast+Ultrasound/26843821.html</guid>
   <pubDate>Thu, 30 Jul 2026 16:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216686</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00175066</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.40307675</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RDNT</category>
   	  </item>
  <item>
   <title>RadNet, Inc. Announces Date of its Second Quarter 2026 Financial Results Conference Call</title>
   <link>http://www.streetinsider.com/Press+Releases/RadNet%2C+Inc.+Announces+Date+of+its+Second+Quarter+2026+Financial+Results+Conference+Call/26797365.html</link>
   <description>&lt;p align=&quot;start&quot;&gt;LOS ANGELES, July  22, 2026  (GLOBE NEWSWIRE) -- &lt;strong&gt;RadNet, Inc. (NASDAQ: RDNT)&lt;/strong&gt;, a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient imaging centers and digital health solutions, announced today that it will host a conference call to discuss its second quarter 2026 financial results on Monday, August 10, 2026 at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time).&lt;/p&gt;  &lt;p align=&quot;start&quot;&gt;Investors are invited to listen to RadNet’s conference call by dialing &lt;strong&gt;&lt;u&gt;844-744-1280&lt;/u&gt;&lt;/strong&gt;. International callers can dial &lt;strong&gt;&lt;u&gt;412-564-6465&lt;/u&gt;&lt;/strong&gt;. There will also be simultaneous and archived webcasts available at &lt;a</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/RadNet%2C+Inc.+Announces+Date+of+its+Second+Quarter+2026+Financial+Results+Conference+Call/26797365.html</guid>
   <pubDate>Wed, 22 Jul 2026 06:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">RDNT</category>
   	  </item>
  <item>
   <title>RadNet, Inc. Announces Date of its Second Quarter 2026 Financial Results Conference Call</title>
   <link>http://www.streetinsider.com/Globe+Newswire/RadNet%2C+Inc.+Announces+Date+of+its+Second+Quarter+2026+Financial+Results+Conference+Call/26797365.html</link>
   <description>&lt;p align=&quot;start&quot;&gt;LOS ANGELES, July  22, 2026  (GLOBE NEWSWIRE) -- &lt;strong&gt;RadNet, Inc. (NASDAQ: RDNT)&lt;/strong&gt;, a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient imaging centers and digital health solutions, announced today that it will host a conference call to discuss its second quarter 2026 financial results on Monday, August 10, 2026 at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time).&lt;/p&gt;  &lt;p align=&quot;start&quot;&gt;Investors are invited to listen to RadNet’s conference call by dialing &lt;strong&gt;&lt;u&gt;844-744-1280&lt;/u&gt;&lt;/strong&gt;. International callers can dial &lt;strong&gt;&lt;u&gt;412-564-6465&lt;/u&gt;&lt;/strong&gt;. There will also be simultaneous and archived webcasts available at &lt;a</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/RadNet%2C+Inc.+Announces+Date+of+its+Second+Quarter+2026+Financial+Results+Conference+Call/26797365.html</guid>
   <pubDate>Wed, 22 Jul 2026 06:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">RDNT</category>
   	  </item>
  <item>
   <title>DeepHealth gets FDA clearance for two new breast imaging AI tools</title>
   <link>http://www.streetinsider.com/Corporate+News/DeepHealth+gets+FDA+clearance+for+two+new+breast+imaging+AI+tools/26687442.html</link>
   <description>&lt;p&gt;DeepHealth, Inc., a subsidiary of RadNet, Inc. (NASDAQ: RDNT), has received two FDA 510(k) clearances for new functionalities within its Breast Suite AI platform, according to a company statement.&lt;/p&gt;&lt;p&gt;The first clearance covers Breast Arterial Calcification (BAC) Assessment, a tool that automatically identifies breast arterial calcifications on standard 2D and 3D screening mammograms without requiring additional imaging. Breast arterial calcifications visible on mammograms have been linked to an elevated risk of cardiovascular events including heart attacks and strokes. In clinical performance testing, the tool demonstrated more than 90% sensitivity and more than 88% specificity in identifying arterial calcifications across both dense</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/DeepHealth+gets+FDA+clearance+for+two+new+breast+imaging+AI+tools/26687442.html</guid>
   <pubDate>Thu, 25 Jun 2026 06:00:38 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">RDNT</category>
   	  </item>
  <item>
   <title>DeepHealth gets FDA clearance for two new breast imaging AI tools</title>
   <link>http://www.streetinsider.com/FDA/DeepHealth+gets+FDA+clearance+for+two+new+breast+imaging+AI+tools/26687442.html</link>
   <description>&lt;p&gt;DeepHealth, Inc., a subsidiary of RadNet, Inc. (NASDAQ: RDNT), has received two FDA 510(k) clearances for new functionalities within its Breast Suite AI platform, according to a company statement.&lt;/p&gt;&lt;p&gt;The first clearance covers Breast Arterial Calcification (BAC) Assessment, a tool that automatically identifies breast arterial calcifications on standard 2D and 3D screening mammograms without requiring additional imaging. Breast arterial calcifications visible on mammograms have been linked to an elevated risk of cardiovascular events including heart attacks and strokes. In clinical performance testing, the tool demonstrated more than 90% sensitivity and more than 88% specificity in identifying arterial calcifications across both dense</description>
   <guid isPermaLink="true">http://www.streetinsider.com/FDA/DeepHealth+gets+FDA+clearance+for+two+new+breast+imaging+AI+tools/26687442.html</guid>
   <pubDate>Thu, 25 Jun 2026 06:00:38 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">RDNT</category>
   	  </item>
  <item>
   <title>DeepHealth Receives Two FDA Clearances Enabling it to Add Cardiovascular Insights and Prior Exam Integration to its AI-Powered Breast Suite</title>
   <link>http://www.streetinsider.com/Press+Releases/DeepHealth+Receives+Two+FDA+Clearances+Enabling+it+to+Add+Cardiovascular+Insights+and+Prior+Exam+Integration+to+its+AI-Powered+Breast+Suite/26687411.html</link>
   <description>&lt;p&gt;&lt;strong&gt;New capabilities are designed to improve cancer detection and recall rates and enable physicians to make informed cardiovascular decisions&lt;/strong&gt;&lt;/p&gt;&lt;p align=&quot;left&quot;&gt;SOMERVILLE, Mass., June  25, 2026  (GLOBE NEWSWIRE) -- DeepHealth, Inc., a leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (NASDAQ: RDNT), announces it has received FDA 510(k) clearances for two new Breast Suite&lt;sup&gt;1&lt;/sup&gt; functionalities:&lt;/p&gt;  &lt;ul&gt;&lt;li&gt;&lt;strong&gt;Breast Arterial Calcification (BAC) Assessment&lt;/strong&gt;, a tool applied to standard screening mammograms that automatically identifies breast arterial calcifications, a potential early indicator of cardiovascular disease;&lt;sup&gt;2&lt;/sup&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;Prior exam integration into ProFound Pro&lt;/strong&gt;, which enables automatic processing of prior and current studies</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/DeepHealth+Receives+Two+FDA+Clearances+Enabling+it+to+Add+Cardiovascular+Insights+and+Prior+Exam+Integration+to+its+AI-Powered+Breast+Suite/26687411.html</guid>
   <pubDate>Thu, 25 Jun 2026 06:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">RDNT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RDNT</category>
   	  </item>
  <item>
   <title>DeepHealth Receives Two FDA Clearances Enabling it to Add Cardiovascular Insights and Prior Exam Integration to its AI-Powered Breast Suite</title>
   <link>http://www.streetinsider.com/Press+Releases/DeepHealth+Receives+Two+FDA+Clearances+Enabling+it+to+Add+Cardiovascular+Insights+and+Prior+Exam+Integration+to+its+AI-Powered+Breast+Suite/26687411.html</link>
   <description>&lt;p&gt;&lt;strong&gt;New capabilities are designed to improve cancer detection and recall rates and enable physicians to make informed cardiovascular decisions&lt;/strong&gt;&lt;/p&gt;&lt;p align=&quot;left&quot;&gt;SOMERVILLE, Mass., June  25, 2026  (GLOBE NEWSWIRE) -- DeepHealth, Inc., a leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (NASDAQ: RDNT), announces it has received FDA 510(k) clearances for two new Breast Suite&lt;sup&gt;1&lt;/sup&gt; functionalities:&lt;/p&gt;  &lt;ul&gt;&lt;li&gt;&lt;strong&gt;Breast Arterial Calcification (BAC) Assessment&lt;/strong&gt;, a tool applied to standard screening mammograms that automatically identifies breast arterial calcifications, a potential early indicator of cardiovascular disease;&lt;sup&gt;2&lt;/sup&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;Prior exam integration into ProFound Pro&lt;/strong&gt;, which enables automatic processing of prior and current studies</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/DeepHealth+Receives+Two+FDA+Clearances+Enabling+it+to+Add+Cardiovascular+Insights+and+Prior+Exam+Integration+to+its+AI-Powered+Breast+Suite/26687411.html</guid>
   <pubDate>Thu, 25 Jun 2026 06:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">RDNT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RDNT</category>
   	  </item>
  <item>
   <title>DeepHealth Receives Two FDA Clearances Enabling it to Add Cardiovascular Insights and Prior Exam Integration to its AI-Powered Breast Suite</title>
   <link>http://www.streetinsider.com/Globe+Newswire/DeepHealth+Receives+Two+FDA+Clearances+Enabling+it+to+Add+Cardiovascular+Insights+and+Prior+Exam+Integration+to+its+AI-Powered+Breast+Suite/26687411.html</link>
   <description>&lt;p&gt;&lt;strong&gt;New capabilities are designed to improve cancer detection and recall rates and enable physicians to make informed cardiovascular decisions&lt;/strong&gt;&lt;/p&gt;&lt;p align=&quot;left&quot;&gt;SOMERVILLE, Mass., June  25, 2026  (GLOBE NEWSWIRE) -- DeepHealth, Inc., a leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (NASDAQ: RDNT), announces it has received FDA 510(k) clearances for two new Breast Suite&lt;sup&gt;1&lt;/sup&gt; functionalities:&lt;/p&gt;  &lt;ul&gt;&lt;li&gt;&lt;strong&gt;Breast Arterial Calcification (BAC) Assessment&lt;/strong&gt;, a tool applied to standard screening mammograms that automatically identifies breast arterial calcifications, a potential early indicator of cardiovascular disease;&lt;sup&gt;2&lt;/sup&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;Prior exam integration into ProFound Pro&lt;/strong&gt;, which enables automatic processing of prior and current studies</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/DeepHealth+Receives+Two+FDA+Clearances+Enabling+it+to+Add+Cardiovascular+Insights+and+Prior+Exam+Integration+to+its+AI-Powered+Breast+Suite/26687411.html</guid>
   <pubDate>Thu, 25 Jun 2026 06:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">RDNT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RDNT</category>
   	  </item>
  <item>
   <title>DeepHealth Receives Two FDA Clearances Enabling it to Add Cardiovascular Insights and Prior Exam Integration to its AI-Powered Breast Suite</title>
   <link>http://www.streetinsider.com/Globe+Newswire/DeepHealth+Receives+Two+FDA+Clearances+Enabling+it+to+Add+Cardiovascular+Insights+and+Prior+Exam+Integration+to+its+AI-Powered+Breast+Suite/26687411.html</link>
   <description>&lt;p&gt;&lt;strong&gt;New capabilities are designed to improve cancer detection and recall rates and enable physicians to make informed cardiovascular decisions&lt;/strong&gt;&lt;/p&gt;&lt;p align=&quot;left&quot;&gt;SOMERVILLE, Mass., June  25, 2026  (GLOBE NEWSWIRE) -- DeepHealth, Inc., a leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (NASDAQ: RDNT), announces it has received FDA 510(k) clearances for two new Breast Suite&lt;sup&gt;1&lt;/sup&gt; functionalities:&lt;/p&gt;  &lt;ul&gt;&lt;li&gt;&lt;strong&gt;Breast Arterial Calcification (BAC) Assessment&lt;/strong&gt;, a tool applied to standard screening mammograms that automatically identifies breast arterial calcifications, a potential early indicator of cardiovascular disease;&lt;sup&gt;2&lt;/sup&gt;&lt;/li&gt;&lt;li&gt;&lt;strong&gt;Prior exam integration into ProFound Pro&lt;/strong&gt;, which enables automatic processing of prior and current studies</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/DeepHealth+Receives+Two+FDA+Clearances+Enabling+it+to+Add+Cardiovascular+Insights+and+Prior+Exam+Integration+to+its+AI-Powered+Breast+Suite/26687411.html</guid>
   <pubDate>Thu, 25 Jun 2026 06:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">RDNT</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RDNT</category>
   	  </item>
  <item>
   <title>Form  4          RadNet, Inc.              For: Jun 18  Filed by: SWARTZ DAVID L</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++RadNet%2C+Inc.++++++++++++++For%3A+Jun+18++Filed+by%3A+SWARTZ+DAVID+L/26673294.html</link>
   <description>si-local-file:///var/storage/secattach/20260622/26673294.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++RadNet%2C+Inc.++++++++++++++For%3A+Jun+18++Filed+by%3A+SWARTZ+DAVID+L/26673294.html</guid>
   <pubDate>Mon, 22 Jun 2026 16:16:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.00175066</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RDNT</category>
   	  </item>
  <item>
   <title>Form  4          RadNet, Inc.              For: Jun 18  Filed by: SWARTZ DAVID L</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++RadNet%2C+Inc.++++++++++++++For%3A+Jun+18++Filed+by%3A+SWARTZ+DAVID+L/26673294.html</link>
   <description>si-local-file:///var/storage/secattach/20260622/26673294.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++RadNet%2C+Inc.++++++++++++++For%3A+Jun+18++Filed+by%3A+SWARTZ+DAVID+L/26673294.html</guid>
   <pubDate>Mon, 22 Jun 2026 16:16:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.00175066</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RDNT</category>
   	  </item>
  <item>
   <title>Form  4          RadNet, Inc.              For: Jun 16  Filed by: Wesdorp Cornelis</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++RadNet%2C+Inc.++++++++++++++For%3A+Jun+16++Filed+by%3A+Wesdorp+Cornelis/26667501.html</link>
   <description>si-local-file:///var/storage/secattach/20260618/26667501.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++RadNet%2C+Inc.++++++++++++++For%3A+Jun+16++Filed+by%3A+Wesdorp+Cornelis/26667501.html</guid>
   <pubDate>Thu, 18 Jun 2026 18:03:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.00175066</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RDNT</category>
   	  </item>
  <item>
   <title>Form  4          RadNet, Inc.              For: Jun 16  Filed by: Wesdorp Cornelis</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++RadNet%2C+Inc.++++++++++++++For%3A+Jun+16++Filed+by%3A+Wesdorp+Cornelis/26667501.html</link>
   <description>si-local-file:///var/storage/secattach/20260618/26667501.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++RadNet%2C+Inc.++++++++++++++For%3A+Jun+16++Filed+by%3A+Wesdorp+Cornelis/26667501.html</guid>
   <pubDate>Thu, 18 Jun 2026 18:03:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.00175066</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RDNT</category>
   	  </item>
  <item>
   <title>Form  4          RadNet, Inc.              For: Jun 16  Filed by: Berger Howard G</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++RadNet%2C+Inc.++++++++++++++For%3A+Jun+16++Filed+by%3A+Berger+Howard+G/26667494.html</link>
   <description>si-local-file:///var/storage/secattach/20260618/26667494.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++RadNet%2C+Inc.++++++++++++++For%3A+Jun+16++Filed+by%3A+Berger+Howard+G/26667494.html</guid>
   <pubDate>Thu, 18 Jun 2026 18:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.00175066</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RDNT</category>
   	  </item>
  <item>
   <title>Form  4          RadNet, Inc.              For: Jun 16  Filed by: Berger Howard G</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++RadNet%2C+Inc.++++++++++++++For%3A+Jun+16++Filed+by%3A+Berger+Howard+G/26667494.html</link>
   <description>si-local-file:///var/storage/secattach/20260618/26667494.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++RadNet%2C+Inc.++++++++++++++For%3A+Jun+16++Filed+by%3A+Berger+Howard+G/26667494.html</guid>
   <pubDate>Thu, 18 Jun 2026 18:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.00175066</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RDNT</category>
   	  </item>
  <item>
   <title>Form  144        RadNet, Inc.                           Filed by: SWARTZ DAVID L</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++144++++++++RadNet%2C+Inc.+++++++++++++++++++++++++++Filed+by%3A+SWARTZ+DAVID+L/26667416.html</link>
   <description>si-local-file:///var/storage/secattach/20260618/26667416.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++144++++++++RadNet%2C+Inc.+++++++++++++++++++++++++++Filed+by%3A+SWARTZ+DAVID+L/26667416.html</guid>
   <pubDate>Thu, 18 Jun 2026 17:31:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.00175066</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RDNT</category>
   	  </item>
 </channel>
</rss>
